Placing a value on your gene therapy innovation

Gene therapies offer dramatic new hope to patients with a range of unmet medical needs—but at what price? From the payer perspective, not all benefits justify reimbursement. And that can spell trouble for manufacturers.

This eye-opening paper from Precision experts Jeremy Schafer, PhD, and Alexander Grosvenor, PhD, will help you:

  • Understand the disparities between payer and manufacturer expectations for long-term outcomes
  • Determine which elements of treatment are included in the product cost
  • Shift the dialogue from short-term results to long-term savings
  • Gain 6 strategies to craft a compelling value story for a gene therapy

Don’t wait to develop your engagement strategy. Download the paper today.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.